NCT00098020View on ClinicalTrials.gov

Podocyte Retinoids

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 26, 2004

Primary Completion Date

June 27, 2016

Study Completion Date

June 27, 2016

Conditions
Collapsing GlomerulopathyGlomerulosclerosis, Focal Segmental
Interventions
DRUG

Isotretinoin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00098020 - Podocyte Retinoids | Biotech Hunter | Biotech Hunter